New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - azathioprine 25mg;   - film coated tablet - 25 mg - active: azathioprine 25mg   excipient: croscarmellose sodium maize starch mannitol microcrystalline cellulose opadry clear oy-7240 povidone sodium stearyl fumarate - azamun is used as an immunosuppressant anti-metabolite either alone, or more commonly in combination with other agents (usually corticosteroids) and procedures that influence the immune response. the therapeutic effect of azamun may be evident only after weeks or months and can include a steroid-sparing effect, thereby reducing the toxicity associated with high dosage and prolonged use of corticosteroids. azamun, in combination with corticosteroids and/or other immune-suppressive agents and procedures is indicated to enhance survival of organ transplants, such as renal, cardiac and hepatic transplants; and to reduce corticosteroid requirements of renal transplant recipients.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - azathioprine 75mg;   - film coated tablet - 75 mg - active: azathioprine 75mg   excipient: croscarmellose sodium maize starch mannitol microcrystalline cellulose opadry clear oy-7240 povidone sodium stearyl fumarate - azamun is used as an immunosuppressant anti-metabolite either alone, or more commonly in combination with other agents (usually corticosteroids) and procedures that influence the immune response. the therapeutic effect of azamun may be evident only after weeks or months and can include a steroid-sparing effect, thereby reducing the toxicity associated with high dosage and prolonged use of corticosteroids. azamun, in combination with corticosteroids and/or other immune-suppressive agents and procedures is indicated to enhance survival of organ transplants, such as renal, cardiac and hepatic transplants; and to reduce corticosteroid requirements of renal transplant recipients.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - fusidic acid 20.35 mg/g (as the 0.5 hydrate) - topical cream - 20 mg/g - active: fusidic acid 20.35 mg/g (as the 0.5 hydrate) excipient: butylated hydroxyanisole cetyl alcohol glycerol hydrochloric acid liquid paraffin polysorbate 60 potassium sorbate purified water white soft paraffin - indicated either alone or in combination with systemic therapy, in the treatment of primary and secondary skin infections caused by sensitive strains of staphylococcus aureus, streptococcus spp and corynebacterium minutissimum. primary skin infections that may be expected to respond to treatment with fusidic acid applied topically include: impetigo contagiosa, superficial folliculitis, sycosis barbae, paronychia and erythrasma; also such secondary skin infections as infected eczematoid dermatitis, infected contact dermatitis and infected cuts/abrasions.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - fluorouracil 5%{relative};  ;   - topical cream - 5% w/w - active: fluorouracil 5%{relative}     excipient: methyl hydroxybenzoate polysorbate 60 propyl hydroxybenzoate propylene glycol purified water stearyl alcohol white soft paraffin - dp-fluorouracil is used for the topical treatment of superficial pre-malignant and malignant skin lesions; keratoses including senile, actinic and arsenical forms, keratoa canthoma; bowen's disease; superficial basal-cell carcinoma.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - dutasteride 0.5mg - soft gelatin capsule - 500 mcg - active: dutasteride 0.5mg excipient: butylated hydroxytoluene gelatin glycerol iron oxide red iron oxide yellow octanoic/decanoic acid glycerides titanium dioxide - terod is indicated for the treatment of, and to prevent progression of benign prostatic hyperplasia (bph) by reducing prostate size, alleviating symptoms, improving urinary flow and reducing the risk of acute urinary retention (aur) and the need for bph related surgery. terod is indicated for use as combination therapy in the management of symptomatic bph with an alpha blocker which is approved for use in bph and which has been dose titrated in accordance with the relevant recommendation in the product information for that alpha blocker.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - alitretinoin 10mg - liquid filled capsule - 10 mg - active: alitretinoin 10mg excipient: dl-alpha tocopherol gelatin glycerol glyceryl 1-monostearate hydrogenated vegetable oil iron oxide black iron oxide red iron oxide yellow medium-chain triglycerides purified water sorbitol soya bean oil, hydrogenated soya oil titanium dioxide - zematane is indicated for use in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids. patients in whom the eczema has predominantly hyperkeratotic features are more likely to respond to treatment than in those in whom the eczema predominantly presents as pompholyx.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - alitretinoin 30mg - liquid filled capsule - 30 mg - active: alitretinoin 30mg excipient: dl-alpha tocopherol gelatin glycerol glyceryl 1-monostearate hydrogenated vegetable oil iron oxide yellow medium-chain triglycerides purified water sorbitol soya bean oil, hydrogenated soya oil titanium dioxide - zematane is indicated for use in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids. patients in whom the eczema has predominantly hyperkeratotic features are more likely to respond to treatment than in those in whom the eczema predominantly presents as pompholyx.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - captopril 5 mg/ml - oral solution - 5 mg/ml - active: captopril 5 mg/ml excipient: citric acid monohydrate disodium edetate purified water sodium benzoate sodium citrate - dp-captopril is indicated for the treatment of hypertension. in using dp-captopril, consideration should be given to the risk of neutropenia/agranulocytosis (see section 4.4 special warnings and precautions for use). dp-captopril is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of captopril and thiazides are approximately additive.

Australia - English - Department of Health (Therapeutic Goods Administration)

douglas pharmaceuticals australia pty ltd - acitretin, quantity: 10 mg - capsule, hard - excipient ingredients: titanium dioxide; purified water; sodium lauryl sulfate; iron oxide red; gelatin; maltodextrin; microcrystalline cellulose; sodium ascorbate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - acitretin may be used for the treatment of:,? severe intractable psoriasis in all its forms,? severe forms of disorders of keratinisation such as,- hyperkeratosis palmaris et plantaris,- pustulosis palmaris et plantaris,- ichthyosis,- keratosis follicularis (darier's disease),- lichen planus affecting the skin or the mucosae,- pityriasis rubra pilaris

Australia - English - Department of Health (Therapeutic Goods Administration)

douglas pharmaceuticals australia pty ltd - acitretin, quantity: 25 mg - capsule, hard - excipient ingredients: titanium dioxide; microcrystalline cellulose; purified water; iron oxide red; sodium ascorbate; iron oxide yellow; gelatin; maltodextrin; sodium lauryl sulfate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - acitretin may be used for the treatment of:,? severe intractable psoriasis in all its forms,? severe forms of disorders of keratinisation such as,- hyperkeratosis palmaris et plantaris,- pustulosis palmaris et plantaris,- ichthyosis,- keratosis follicularis (darier's disease),- lichen planus affecting the skin or the mucosae,- pityriasis rubra pilaris